Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mead

Showing results (341-350 of 435) with videos related to

Pageof 44
Sort By:
Free Radical Biology & Medicine|April 24, 2013
S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosisRichard J Mead, Adrian Higginbottom, Scott P Allen, et al.
Transplantation|March 4, 1998
Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantationK A Newell, J M Millis, P M Arnow, et al.
British Journal of Haematology|November 28, 2018
A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology GuidelineMary Frances McMullin, Claire N Harrison, Sahra Ali, et al.
British Journal of Haematology|November 15, 2018
A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: A British Society for Haematology GuidelineMary F F McMullin, Adam J Mead, Sahra Ali, et al.
British Journal of Haematology|January 24, 2017
Guideline for the investigation and management of eosinophiliaNauman M Butt, Jonathan Lambert, Sahra Ali, et al.
Blood|August 8, 2012
Dicer is selectively important for the earliest stages of erythroid developmentNatalija Buza-Vidas, Valeriu B Cismasiu, Susan Moore, et al.
Blood|April 8, 2010
HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioningAdam J Mead, Kirsty J Thomson, Emma C Morris, et al.
British Journal of Haematology|August 1, 2020
A British Society for Haematology Guideline on the diagnosis and management of chronic myeloid leukaemiaGraeme Smith, Jane Apperley, Dragana Milojkovic, et al.
Journal of Hepatology|November 16, 2020
ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinomaMaria Arechederra, Sehrish K Bazai, Ahmed Abdouni, et al.
British Journal of Haematology|June 16, 2021
Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasmsOnima Chowdhury, Hannah Bruguier, Garry Mallett, et al.
Pageof 44

Showing results (341-350 of 435) with videos related to

Sort By:
Pageof 44
Free Radical Biology & Medicine|April 24, 2013
S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosisRichard J Mead, Adrian Higginbottom, Scott P Allen, et al.
Transplantation|March 4, 1998
Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantationK A Newell, J M Millis, P M Arnow, et al.
British Journal of Haematology|November 28, 2018
A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology GuidelineMary Frances McMullin, Claire N Harrison, Sahra Ali, et al.
British Journal of Haematology|November 15, 2018
A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: A British Society for Haematology GuidelineMary F F McMullin, Adam J Mead, Sahra Ali, et al.
British Journal of Haematology|January 24, 2017
Guideline for the investigation and management of eosinophiliaNauman M Butt, Jonathan Lambert, Sahra Ali, et al.
Blood|August 8, 2012
Dicer is selectively important for the earliest stages of erythroid developmentNatalija Buza-Vidas, Valeriu B Cismasiu, Susan Moore, et al.
Blood|April 8, 2010
HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioningAdam J Mead, Kirsty J Thomson, Emma C Morris, et al.
British Journal of Haematology|August 1, 2020
A British Society for Haematology Guideline on the diagnosis and management of chronic myeloid leukaemiaGraeme Smith, Jane Apperley, Dragana Milojkovic, et al.
Journal of Hepatology|November 16, 2020
ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinomaMaria Arechederra, Sehrish K Bazai, Ahmed Abdouni, et al.
British Journal of Haematology|June 16, 2021
Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasmsOnima Chowdhury, Hannah Bruguier, Garry Mallett, et al.
Pageof 44